|
1
|
Ciavardelli D, Bellomo M, Consalvo A,
Crescimanno C and Vella V: Metabolic alterations of thyroid cancer
as potential therapeutic targets. Biomed Res Int. 2017:25450312017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vaccarella S, Franceschi S, Bray F, Wild
CP, Plummer M and Dal Maso L: Worldwide thyroid-cancer epidemic?
The increasing impact of overdiagnosis. N Engl J Med. 375:614–617.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sanabria A, Kowalski LP, Shah JP, Nixon
IJ, Angelos P, Williams MD, Rinaldo A and Ferlito A: Growing
incidence of thyroid carcinoma in recent years: Factors underlying
overdiagnosis. Head Neck. 40:855–866. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haramati S, Chapnik E, Sztainberg Y, Eilam
R, Zwang R, Gershoni N, McGlinn E, Heiser PW, Wills AM, Wirguin I,
et al: miRNA malfunction causes spinal motor neuron disease. Proc
Natl Acad Sci USA. 107:13111–13116. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lacouture ME, Ciccolini K, Kloos RT and
Agulnik M: Overview and management of dermatologic events
associated with targeted therapies for medullary thyroid cancer.
Thyroid. 24:1329–1340. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim H, Kim YN, Kim HI, Park SY, Choe JH,
Kim JH, Kim JS, Chung JH, Kim TH and Kim SW: Preoperative serum
thyroglobulin predicts initial distant metastasis in patients with
differentiated thyroid cancer. Sci Rep. 7:169552017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang M, Qiu S and Qin J: Baicalein induced
apoptosis and autophagy of undifferentiated thyroid cancer cells by
the ERK/PI3K/Akt pathway. Am J Transl Res. 11:3341–3352.
2019.PubMed/NCBI
|
|
9
|
Jung CW, Han KH, Seol H, et al: Expression
of cancer stem cell markers and epithelial-mesenchymal
transition-related factors in anaplastic thyroid carcinoma.
International journal of clinical and experimental pathology.
8:560–568. 2015.PubMed/NCBI
|
|
10
|
Sandberg K, Samson WK and Ji H: Decoding
noncoding RNA: da Vinci redux? Circ Res. 113:240–241. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Diamantopoulos MA, Tsiakanikas P and
Scorilas A: Non-coding RNAs: The riddle of the transcriptome and
their perspectives in cancer. Ann Transl Med. 6:2412018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dai M, Li S and Qin X: Colorectal
neoplasia differentially expressed: A long noncoding RNA with an
imperative role in cancer. Onco Targets Ther. 11:3755–3763. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ogoyama M, Ohkuchi A, Takahashi H, Zhao D,
Matsubara S and Takizawa T: LncRNA H19-derived miR-675-5p
accelerates the invasion of extravillous trophoblast cells by
inhibiting GATA2 and subsequently activating matrix
metalloproteinases. Int J Mol Sci. 22:12372021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Muhammad N, Bhattacharya S, Steele R and
Ray RB: Anti-miR-203 suppresses ER-positive breast cancer growth
and stemness by targeting SOCS3. Oncotarget. 7:58595–58605. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yanaihara N and Harris CC: MicroRNA
involvement in human cancers. Clin Chem. 59:1811–1812. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rosignolo F, Memeo L, Monzani F, Colarossi
C, Pecce V, Verrienti A, Durante C, Grani G, Lamartina L, Forte S,
et al: MicroRNA-based molecular classification of papillary thyroid
carcinoma. Int J Oncol. 50:1767–1777. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dong S, Xue S, Sun Y, Han Z, Sun L, Xu J
and Liu J: MicroRNA-363-3p downregulation in papillary thyroid
cancer inhibits tumor progression by targeting NOB1. J Investig
Med. 69:66–74. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu HM, Dong AB, Hua H, Sun YH, Wang JR,
Yu QQ, Zhang JH and Sun WH: MicroRNA-219 inhibits cell viability
and metastasis in papillary thyroid carcinoma by targeting EYA2.
Eur Rev Med Pharmacol Sci. 24:9556–9564. 2020.PubMed/NCBI
|
|
20
|
Li N, Mao D, Cao Y, Li H, Ren F and Li K:
Downregulation of SIRT6 by miR-34c-5p is associated with poor
prognosis and promotes colon cancer proliferation through
inhibiting apoptosis via the JAK2/STAT3 signaling pathway. Int J
Oncol. 52:1515–1527. 2018.PubMed/NCBI
|
|
21
|
Liang M, Yu S, Tang S, Bai L, Cheng J, Gu
Y, Li S, Zheng X, Duan L, Wang L, et al: A panel of plasma exosomal
mirnas as potential biomarkers for differential diagnosis of
thyroid nodules. Front Genet. 11:4492020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen Y, Xu J, Pan X, Zhang Y, Weng Y, Zhou
D and He S: LncRNA KCNQ1OT1 sponges miR-34c-5p to promote
osteosarcoma growth via ALDOA enhanced aerobic glycolysis. Cell
Death Dis. 11:2782020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yanokura M, Banno K and Aoki D:
MicroRNA-34b expression enhances chemosensitivity of endometrial
cancer cells to paclitaxel. Int J Oncol. 57:1145–1156.
2020.PubMed/NCBI
|
|
24
|
Lin BZ, Wan SY, Lin MY, Chang CH, Chen TW,
Yang MH and Lee YJ: Involvement of differentially expressed
microRNAs in the PEGylated liposome encapsulated
188rhenium-mediated suppression of orthotopic
hypopharyngeal tumor. Molecules. 25:36092020. View Article : Google Scholar
|
|
25
|
Wang H, Bian S and Yang CS: Green tea
polyphenol EGCG suppresses lung cancer cell growth through
upregulating miR-210 expression caused by stabilizing HIF-1α.
Carcinogenesis. 32:1881–1889. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kazimierczyk M, Kasprowicz MK, Kasprzyk ME
and Wrzesinski J: Human long noncoding RNA interactome: detection,
characterization and function. Int J Mol Sci. 21:10272020.
View Article : Google Scholar
|
|
27
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fan H, Ge Y, Ma X, Li Z, Shi L, Lin L,
Xiao J, Chen W, Ni P, Yang L and Xu Z: Long non-coding RNA
CCDC144NL-AS1 sponges miR-143-3p and regulates MAP3K7 by acting as
a competing endogenous RNA in gastric cancer. Cell Death Dis.
11:5212020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu H, Zhong X, Gao P, Shi J, Wu Z, Guo Z,
Wang Z and Song Y: The potential effect of metformin on cancer: An
umbrella review. Front Endocrinol (Lausanne). 10:6172019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bayat Mokhtari R, Homayouni TS, Baluch N,
Morgatskaya E, Kumar S, Das B and Yeger H: Combination therapy in
combating cancer. Oncotarget. 8:38022–38043. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Muhammad N, Steele R, Isbell TS, Philips N
and Ray RB: Bitter melon extract inhibits breast cancer growth in
preclinical model by inducing autophagic cell death. Oncotarget.
8:66226–66236. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mohammad N, Malvi P, Meena AS, Singh SV,
Chaube B, Vannuruswamy G, Kulkarni MJ and Bhat MK: Cholesterol
depletion by methyl-β-cyclodextrin augments tamoxifen induced cell
death by enhancing its uptake in melanoma. Mol Cancer. 13:2042014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mohammad N, Singh SV, Malvi P, Chaube B,
Athavale D, Vanuopadath M, Nair SS, Nair B and Bhat MK: Strategy to
enhance efficacy of doxorubicin in solid tumor cells by
methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand
complex. Sci Rep. 5:118532015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gupta A, Williams BR, Hanash SM and Rawwas
J: Cellular retinoic acid-binding protein II is a direct
transcriptional target of MycN in neuroblastoma. Cancer Res.
66:8100–8108. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gupta A, Kessler P, Rawwas J and Williams
BR: Regulation of CRABP-II expression by MycN in Wilms tumor. Exp
Cell Res. 314:3663–3668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Favorskaya I, Kainov Y, Chemeris G,
Komelkov A, Zborovskaya I and Tchevkina E: Expression and clinical
significance of CRABP1 and CRABP2 in non-small cell lung cancer.
Tumour Biol:. 35:10295–10300. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Donato LJ and Noy N: Suppression of
mammary carcinoma growth by retinoic acid: Proapoptotic genes are
targets for retinoic acid receptor and cellular retinoic
acid-binding protein II signaling. Cancer Res. 65:8193–8199. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Budhu AS and Noy N: Direct channeling of
retinoic acid between cellular retinoic acid-binding protein II and
retinoic acid receptor sensitizes mammary carcinoma cells to
retinoic acid-induced growth arrest. Mol Cell Biol. 22:2632–2641.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42((Database Issue)): D92–D97. 2013.PubMed/NCBI
|
|
42
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
|
43
|
Jiao X, Sherman BT, Huang da W, Stephens
R, Baseler MW, Lane HC and Lempicki RA: DAVID-WS: A stateful web
service to facilitate gene/protein list analysis. Bioinformatics.
28:1805–1806. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jonklaas J, Nsouli-Maktabi H and Soldin
SJ: Endogenous thyrotropin and triiodothyronine concentrations in
individuals with thyroid cancer. Thyroid. 18:943–952. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jiang W, Cai F, Xu H, Lu Y, Chen J, Liu J,
Cao N, Zhang X, Chen X, Huang Q, et al: Extracellular signal
regulated kinase 5 promotes cell migration, invasion and lung
metastasis in a FAK-dependent manner. Protein Cell. 11:825–845.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mahtouk K, Jourdan M, De Vos J, Hertogh C,
Fiol G, Jourdan E, Rossi JF and Klein B: An inhibitor of the EGF
receptor family blocks myeloma cell growth factor activity of
HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced
apoptosis. Blood. 103:1829–1837. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Brito JP, Morris JC and Montori VM:
Thyroid cancer: Zealous imaging has increased detection and
treatment of low risk tumours. BMJ. 347:f47062013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lirov R, Worden FP and Cohen MS: The
treatment of advanced thyroid cancer in the age of novel targeted
therapies. Drugs. 77:733–745. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rashid F, Shah A and Shan G: Long
non-coding RNAs in the cytoplasm. Genomics Proteomics
Bioinformatics. 14:73–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tung SL, Huang WC, Hsu FC, Yang ZP, Jang
TH, Chang JW, Chuang CM, Lai CR and Wang LH: miRNA-34c-5p inhibits
amphiregulin-induced ovarian cancer stemness and drug resistance
via downregulation of the AREG-EGFR-ERK pathway. Oncogenesis.
6:e3262017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang Y, Wang X, Tang J, Su X and Miao Y:
The study of mechanism of miR-34c-5p targeting FLOT2 to regulate
proliferation, migration and invasion of osteosarcoma cells. Artif
Cells Nanomed Biotechnol. 47:3559–3568. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yuan J, Tang Z, Yang S and Li K: CRABP2
promotes myoblast differentiation and is modulated by the
transcription factors MyoD and Sp1 in C2C12 cells. PLoS One.
8:e554792013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Okuducu AF, Janzen V, Ko Y, Hahne JC, Lu
H, Ma ZL, Albers P, Sahin A, Wellmann A, Scheinert P and Wernert N:
Cellular retinoic acid-binding protein 2 is down-regulated in
prostate cancer. Int J Oncol. 27:1273–1282. 2005.PubMed/NCBI
|
|
54
|
Wu JI, Lin YP, Tseng CW, Chen HJ and Wang
LH: Crabp2 promotes metastasis of lung cancer cells via HuR and
integrin β1/FAK/ERK signaling. Sci Rep. 9:8452019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li YT, Tian XT, Wu ML, Zheng X, Kong QY,
Cheng XX, Zhu GW, Liu J and Li H: Resveratrol suppresses the growth
and enhances retinoic acid sensitivity of anaplastic thyroid cancer
cells. Int J Mol Sci. 19:10302018. View Article : Google Scholar
|
|
56
|
Liu RZ, Li S, Garcia E, Glubrecht DD, Poon
HY, Easaw JC and Godbout R: Association between cytoplasmic CRABP2,
altered retinoic acid signaling, and poor prognosis in
glioblastoma. Glia. 64:963–976. 2016.PubMed/NCBI
|
